Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6de059489f7dc870d2a8509720f8ae03 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D237-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
filingDate |
2014-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_869a2ac7ee82fd99d8f09a9584bc06b4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53957a0de6e3891aef478dc93ed6e089 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_806cc0dc3c6201d40419e42520eb5b11 |
publicationDate |
2019-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-109970741-A |
titleOfInvention |
Aminopyridazinone compounds as protein kinase inhibitors |
abstract |
The present invention relates to aminopyridazinone compounds that are protein kinase inhibitors. The present invention provides compounds of formula (I) and their use for the therapeutic treatment of human cancers including B cell lymphomas and autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus and multiple sclerosis. |
priorityDate |
2014-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |